Literature DB >> 17492541

[Coil embolization of arteriovenous fistulae on in situ saphenous vein bypasses: success rate and complications].

K Krüger1, D Wagner, M Gawenda, D Strohe, J Uedelhoven, J Brunkwall, K Lackner.   

Abstract

PURPOSE: To determine the success and complication rate of coil embolization of arteriovenous fistulae on in situ saphenous vein bypasses. MATERIALS AND
METHOD: 82 AV-fistulae on 30 bypasses (28 patients, 20 men, age 62.5 +/- 8.3 years) were treated using coils. The success rate, complications, duration, amount of contrast material and radiation exposure were measured. Color-coded duplex sonography was performed 1 - 2 days and up to 6 - 18 months after embolization.
RESULTS: The success rate was 68.3 %. The reasons for persistent fistula perfusion were: 96 % fistula not accessible, 4 % reperfusion during thrombolysis. 7 complications were observed in 6 bypasses: failure of placement and retrieving of coil (n = 4), thrombembolic complications with thrombolysis (n = 3). The duration of intervention was 118.3 +/- 46.6 min, the contrast material need was 277.03 +/- 94.0 ml, and the radiation exposure was 10 966 +/- 11 295 cGy/cm (2). Additional balloon dilatation was performed in 30 % of the bypasses. All bypasses were open 1-2 days after intervention. During follow-up, 11 persistent fistulae were detected.
CONCLUSIONS: Coil-embolization of arteriovenous fistulae on saphena magna bypasses proved to be a method with moderate success and complication rates.

Entities:  

Mesh:

Year:  2007        PMID: 17492541     DOI: 10.1055/s-2007-962922

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

Review 1.  [Embolotherapy: principles and indications].

Authors:  P Landwehr; S Arnold; G Voshage; P Reimer
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

2.  Internal iliac artery embolization during an endovascular aneurysm repair with detachable interlock microcoils.

Authors:  Woo Chul Kim; Yong Sun Jeon; Kee Chun Hong; Jang Yong Kim; Soon Gu Cho; Jae Young Park
Journal:  Korean J Radiol       Date:  2014-09-12       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.